{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:25:47Z","timestamp":1714177547225},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"DOI":"10.7759\/cureus.59058","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T11:54:51Z","timestamp":1714132491000},"source":"Crossref","is-referenced-by-count":0,"title":["Gender Differences in the Evaluation and Management of New Acute CHF Due to ATTRwt Cardiac Amyloidosis"],"prefix":"10.7759","author":[{"given":"Michael","family":"Fragner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude","family":"Elsaygh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudarshan S","family":"Srivats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Pink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-020-00205-3","article-title":"Estimating the gender distribution of patients with wild-type transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis","volume":"10","author":"Kroi F","year":"2021","unstructured":"Kroi F, Fischer N, Gezin A, Hashim M, Rozenbaum MH. Estimating the gender distribution of patients with wild-type transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis. Cardiol Ther. 2021, 10:41-55. 10.1007\/s40119-020-00205-3","journal-title":"Cardiol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2021.12.048","article-title":"Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis","volume":"351","author":"Zampieri M","year":"2022","unstructured":"Zampieri M, Argir\u00f2 A, Allinovi M, et al.. Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis. Int J Cardiol. 2022, 351:71-7. 10.1016\/j.ijcard.2021.12.048","journal-title":"Int J Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2019.16","article-title":"Cardiac transthyretin-derived amyloidosis: an emerging target in heart failure with preserved ejection fraction?","volume":"6","author":"Klaassen SH","year":"2020","unstructured":"Klaassen SH, van Veldhuisen DJ, Nienhuis H, van den Berg MP, Hazenberg BP, van der Meer P. Cardiac transthyretin-derived amyloidosis: an emerging target in heart failure with preserved ejection fraction?. Card Fail Rev. 2020, 6:e21. 10.15420\/cfr.2019.16","journal-title":"Card Fail Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia P","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, et al.. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021, 42:1554-68. 10.1093\/eurheartj\/ehab072","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro A","year":"2018","unstructured":"Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Lond). 2018, 18:s30-5. 10.7861\/clinmedicine.18-2-s30","journal-title":"Clin Med (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2217\/whe.09.80","article-title":"Influence of sex hormones and phytoestrogens on heart disease in men and women","volume":"6","author":"Bhupathy P","year":"2010","unstructured":"Bhupathy P, Haines CD, Leinwand LA. Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond). 2010, 6:77-95. 10.2217\/whe.09.80","journal-title":"Womens Health (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1253\/circrep.CR-21-0067","article-title":"Wild-type transthyretin amyloidosis in female patients - consideration of sex differences","volume":"3","author":"Ochi Y","year":"2021","unstructured":"Ochi Y, Kubo T, Baba Y, et al.. Wild-type transthyretin amyloidosis in female patients - consideration of sex differences. Circ Rep. 2021, 3:465-71. 10.1253\/circrep.CR-21-0067","journal-title":"Circ Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-020-10010-8","article-title":"Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges","volume":"26","author":"Bruno M","year":"2021","unstructured":"Bruno M, Casta\u00f1o A, Burton A, Grodin JL. Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges. Heart Fail Rev. 2021, 26:35-45. 10.1007\/s10741-020-10010-8","journal-title":"Heart Fail Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga A","year":"2017","unstructured":"Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017, 8:33. 10.1186\/s13293-017-0152-8","journal-title":"Biol Sex Differ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-022-00265-7","article-title":"Sex differences in wild-type transthyretin amyloidosis: an analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"11","author":"Campbell CM","year":"2022","unstructured":"Campbell CM, LoRusso S, Dispenzieri A, et al.. Sex differences in wild-type transthyretin amyloidosis: an analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Cardiol Ther. 2022, 11:393-405. 10.1007\/s40119-022-00265-7","journal-title":"Cardiol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","author":"Witteles RM","year":"2019","unstructured":"Witteles RM, Bokhari S, Damy T, et al.. Screening for transthyretin amyloid cardiomyopathy in everyday practice. JACC Heart Fail. 2019, 7:709-16. 10.1016\/j.jchf.2019.04.010","journal-title":"JACC Heart Fail"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore JD","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, et al.. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016, 133:2404-12. 10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2021.10.007","article-title":"Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy","volume":"79","author":"Takashio S","year":"2022","unstructured":"Takashio S, Yamada T, Nishi M, et al.. Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy. J Cardiol. 2022, 79:50-7. 10.1016\/j.jjcc.2021.10.007","journal-title":"J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez E","year":"2017","unstructured":"Gonz\u00e1lez-L\u00f3pez E, Gagliardi C, Dominguez F, et al.. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths. Eur Heart J. 2017, 38:1895-904. 10.1093\/eurheartj\/ehx043","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.04.021","article-title":"Early diagnosis and outcome in patients with wild-type transthyretin cardiac amyloidosis","volume":"96","author":"Fumagalli C","year":"2021","unstructured":"Fumagalli C, Zampieri M, Perfetto F, et al.. Early diagnosis and outcome in patients with wild-type transthyretin cardiac amyloidosis. Mayo Clin Proc. 2021, 96:2185-91. 10.1016\/j.mayocp.2021.04.021","journal-title":"Mayo Clin Proc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.12.005","article-title":"The impact of patients with cardiac amyloidosis in HFpEF trials","volume":"9","author":"Oghina S","year":"2021","unstructured":"Oghina S, Bougouin W, B\u00e9zard M, et al.. The impact of patients with cardiac amyloidosis in HFpEF trials. JACC Heart Fail. 2021, 9:169-78. 10.1016\/j.jchf.2020.12.005","journal-title":"JACC Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson MM","year":"2023","unstructured":"Kittleson MM, Ruberg FL, Ambardekar AV, et al.. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023, 81:1076-126. 10.1016\/j.jacc.2022.11.022","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2021.06.007","article-title":"Spironolactone in patients with an echocardiographic HFpEF phenotype suggestive of cardiac amyloidosis: results from TOPCAT","volume":"9","author":"Sperry BW","year":"2021","unstructured":"Sperry BW, Hanna M, Shah SJ, Jaber WA, Spertus JA. Spironolactone in patients with an echocardiographic HFpEF phenotype suggestive of cardiac amyloidosis: results from TOPCAT. JACC Heart Fail. 2021, 9:795-802. 10.1016\/j.jchf.2021.06.007","journal-title":"JACC Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of arrhythmias in cardiac amyloidosis","volume":"6","author":"Giancaterino S","year":"2020","unstructured":"Giancaterino S, Urey MA, Darden D, Hsu JC. Management of arrhythmias in cardiac amyloidosis. JACC Clin Electrophysiol. 2020, 6:351-61. 10.1016\/j.jacep.2020.01.004","journal-title":"JACC Clin Electrophysiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12518","article-title":"Transthyretin cardiac amyloidosis: an update on diagnosis and treatment","volume":"6","author":"Yamamoto H","year":"2019","unstructured":"Yamamoto H, Yokochi T. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. ESC Heart Fail. 2019, 6:1128-39. 10.1002\/ehf2.12518","journal-title":"ESC Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/250218-gender-differences-in-the-evaluation-and-management-of-new-acute-chf-due-to-attrwt-cardiac-amyloidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T11:54:53Z","timestamp":1714132493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/250218-gender-differences-in-the-evaluation-and-management-of-new-acute-chf-due-to-attrwt-cardiac-amyloidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.59058","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}